Ypsomed Holding AG
SIX:YPSN

Watchlist Manager
Ypsomed Holding AG Logo
Ypsomed Holding AG
SIX:YPSN
Watchlist
Price: 343 CHF 1.48% Market Closed
Market Cap: 4.7B CHF
Have any thoughts about
Ypsomed Holding AG?
Write Note
Section:
 

Relative Value

The Relative Value of one YPSN stock under the Base Case scenario is 486.2 CHF. Compared to the current market price of 343 CHF, Ypsomed Holding AG is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

YPSN Relative Value
Base Case
486.2 CHF
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.6
P/S
P/S
Price to Sales
7.6
vs History
19
vs Industry
14
Median 3Y
6.8
Median 5Y
4.8
Industry
2.3
Forward
6.8
More Details
62.9
P/E
P/E
Price to Earnings
62.9
vs History
84
vs Industry
6
Median 3Y
70.3
Median 5Y
79.9
Industry
23
Forward
40.6
More Details
29.9
P/OCF
P/OCF
Price to OCF
29.9
vs History
42
vs Industry
12
Median 3Y
26.2
Median 5Y
27.5
Industry
14.3
More Details
132.4
P/FCFE
P/FCFE
Price to FCFE
132.4
vs History
22
vs Industry
7
Median 3Y
-50.2
Median 5Y
-57.1
Industry
20
More Details
7.5
P/B
P/B
Price to Book Value
7.5
vs History
12
vs Industry
8
Median 3Y
6.1
Median 5Y
5
Industry
2.2
More Details
8
EV/S
EV/S
Enterprise Value to Sales
8
vs History
19
vs Industry
12
Median 3Y
7.1
Median 5Y
5.2
Industry
2.4
Forward
7.2
More Details
22.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
22.7
vs History
38
vs Industry
6
Median 3Y
23.6
Median 5Y
21.7
Industry
5
More Details
30.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.4
vs History
47
vs Industry
8
Median 3Y
28.9
Median 5Y
29.9
Industry
12.9
Forward
21.6
More Details
57.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
57.1
vs History
88
vs Industry
5
Median 3Y
67.8
Median 5Y
81.6
Industry
17.4
Forward
34.3
More Details
31.6
EV/OCF
EV/OCF
Enterprise Value to OCF
31.6
vs History
41
vs Industry
11
Median 3Y
27.4
Median 5Y
28.6
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-74.8
Median 5Y
-54.8
Industry
18.2
More Details
4.5
EV/IC
EV/IC
Enterprise Value to IC
4.5
vs History
20
vs Industry
16
Median 3Y
4.3
Median 5Y
3.2
Industry
1.9
More Details

Multiples Across Competitors

YPSN Competitors Multiples
Ypsomed Holding AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Ypsomed Holding AG
SIX:YPSN
4.7B CHF 7.6 62.9 30.4 57.1
JP
Hoya Corp
TSE:7741
6.8T JPY 8.3 34.8 22.9 27.6
CH
Alcon AG
SIX:ALC
37.8B CHF 4.3 36 17.7 34.3
DK
Coloplast A/S
CSE:COLO B
175.9B DKK 6.5 34.8 22.4 26.4
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 37 18.7 22.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52.2B CNY 11.8 28.2 24.5 24.5
KR
HLB Inc
KOSDAQ:028300
10.1T KRW 194.6 -54.4 -83.7 -79
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.5 11.9
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD 1.4 -17.3 16.7 55.9
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.1 266.5 465.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.6 23.2 38.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Ypsomed Holding AG
SIX:YPSN
Average EV/EBITDA: 45.4
30.4
35%
0.9
JP
Hoya Corp
TSE:7741
22.9
15%
1.5
CH
Alcon AG
SIX:ALC
17.7
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.4
11%
2
US
Align Technology Inc
NASDAQ:ALGN
18.7
15%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.5
27%
0.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -83.7 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.5
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
266.5
12%
22.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1

See Also

Summary
YPSN intrinsic value, competitors valuation, and company profile.
DCF Valuation
YPSN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
YPSN stock valuation using valuation multiples.
Wall Street Estimates
YPSN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
YPSN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 214,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.